Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: Implications for vaccination policy

Clinical Infectious Diseases

Volumn 42, Issue 3, 2006, Pages 315-319

  Marin, Mona ^a,b   Nguyen, Huong Q ^b   Langidrik, Justina R ^c   Edwards, Russell ^c   Briand, Kennar ^c   Papania, Mark J ^b   Seward, Jane F ^b   LeBaron, Charles W ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DIS CONTR AND PREV   (United States)

^c Ministry of Health Marshall Islands   (Marshall Islands)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ARTICLE; CHILD; COMMON COLD; CONJUNCTIVITIS; COUGHING; CROWDING; EPIDEMIC; FEVER; HOUSEHOLD; HUMAN; INFANT; ISLAND (GEOLOGICAL); MAJOR CLINICAL STUDY; MARSHALL ISLANDS; MEASLES; MEASLES VACCINATION; PRIORITY JOURNAL; RASH; VIRUS TRANSMISSION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; DRUG ADMINISTRATION SCHEDULE; HEALTH POLICY; HOUSING; HUMANS; INFANT; MEASLES; MEASLES-MUMPS-RUBELLA VACCINE; MICRONESIA; POPULATION DENSITY; RISK FACTORS; VACCINATION;

EID: 31044433358     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/498902     Document Type: Article

References (33)

1. World Health Organization. Initiative for vaccine research. Available at: http://www.who.int/vaccine_research/diseases/measles/en/. Accessed 1 February 2005.
2. Centers for Disease Control and Prevention. Summary of notifiable diseases-United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1-84.
3. Papania MJ, Seward JF, Redd SB, Lievano F, Harpaz R, Wharton ME. Epidemiology of measles in the United States, 1997-2001. J Infect Dis 2004; 189(Suppl 1):S61-8.
4. Watson JC, Pearson JA, Markowitz LE, et al. An evaluation of measles revaccination among school-entry-aged children. Pediatrics 1996; 97: 613-8.
5. Vitek CR, Aduddell M, Brinton MJ, Hoffman RE, Redd SC. Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine. Pediatr Infect Dis J 1999; 18:620-3.
6. Kolasa MS, Klemperer-Johnson S, Papania MJ. Progress toward implementation of a second-dose measles immunization requirement for all schoolchildren in the united States. J Infect Dis 2004; 189(Suppl 1):S98-103.
7. Hyde TB, Dayan G, Langidrik JR, et al. Measles outbreak in the Republic of the Marshall Islands, 2003. Int J Epidemiol 2005; published online 18 Nov.
8. McIntyre RC, Preblud SR, Polloi A, Korean M. Measles and measles vaccine in a remote island population. Bull World Health Organ 1982; 60:767-75.
9. Cutts FT, Grabowsky M, Markowitz LE. The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants. Biologicals 1995; 23:95-106.
10. Krugman S. Further-attenuated measles vaccine: characteristics and use. Rev Infect Dis 1983; 5:477-81.
11. Gustafson TL, Lievens AW, Brunell PA, Moellenberg RG, Buttery CMG, Sehulster LM. Measles outbreak in a fully immunized secondary-school population. N Engl J Med 1987; 316:771-4.
12. Chen RT, Goldbaum GM, Wassilak SGF, Markowitz LE, Orenstein WA. An explosive point-source measles outbreak in a highly vaccinated population. Am J Epidemiol 1989; 129:173-82.
13. US Census Bureau. Country and city data book: 2000. 13th ed. Washington, DC: US Census Bureau, 2001.
14. World Health Organization (WHO). Recommended standards for surveillance of selected vaccine-preventable diseases. Geneva: WHO, 1999: 13-7.
15. King GE, Markowitz LE, Patriarca PA, Dales LG. Clinical efficacy of measles vaccine during the 1990 measles epidemic. Pediatr Infect Dis J 1991; 10:883-7.
16. Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985; 63:1055-68.
17. Centers for Disease Control and Prevention. HIPAA privacy rule and public health: guidance from CDC and the U.S. Department of Health and Human Services. MMWR Morb Mortal Wkly Rep 2003; 52(Suppl 1):1-12.
18. Poland GA, Jacobson RM, Thampy AM, et al. Measles reimmunization in children seronegative after initial immunization. JAMA 1997; 277: 1156-8.
19. Strebel PM, Papania MJ, Halsey NA. Measles vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. 4th ed. Philadelphia: WB Saunders, 2004: 389-440.
20. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field: further observations. Epidemiol Rev 1988; 10:212-41.
21. Schlenker TL, Bain C, Baughman AL, Hadler SC. Measles herd immunity: the association of attack rates with immunization rates in preschool children. JAMA 1992; 267:823-6.
22. Duke T, Mgone CS. Measles: not just another viral exanthem. Lancet 2003; 361:763-73.
23. Papania M, Baughman AL, Lee S, et al. Increased susceptibility to measles in infants in the United States. Pediatrics 1999; 104:e59.
24. De Serres G, Joly JH, Fauvel M, Meyer F, Masse B, Boulianne N. Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles. Vaccine 1997; 15:620-3.
25. Maldonado YA, Lawrence EC, DeHovitz R, Hartzell H, Albrecht A. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics 1995; 96:447-50.
26. Stetler HS, Orenstein WA, Bernier RH, et al. Impact of revaccinating children who initially received measles vaccine before 10 months of age. Pediatrics 1986; 77:471-6.
27. Hutchins SS, Dezayas A, Le Blond K, et al. Evaluation of an early two-dose measles vaccination schedule. Am J Epidemiol 2001; 154:1064-71.
28. Gans HA, Yasukawa LL, Alderson A, et al. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States. J Infect Dis 2004; 190:83-90.
29. Fine PE, Clarkson JA, Miller E. The efficacy of pertussis vaccines under conditions of household exposure. Int J Epidemiol 1988; 17:635-42.
30. Six C, Franke F, Mantey K, et al. Measles outbreak in the Provence-Alpes-Cote d'Azur region, France, January-July 2003. Euro Surveill 2005; 10:46-8.
31. Ciofi degli Atti M, Salmaso S. New measles epidemic in southern Italy: 1217 cases reported to sentinel surveillance, January-May 2003. Eurosurveillance Wkly 2003; 7. Available at: http://www.eurosurveillance .org/ew/2003/030703. asp. Accessed 1 August 2005.
32. Gee S, Carton M, Cotter S. Measles increase in Ireland, 2004. Eurosurveillance Wkly 2004; 8. Available at: http://www.eurosurveillance .org/ew/2004/040923.asp. Accessed 1 August 2005.
33. Siedler A. Measles outbreaks in Hessen and Bavaria, Germany, 2005. Eurosurveillance Wkly 2005; 10. Available at: http://www.eurosurveillance .org/ew/2005/050728.asp. Accessed 1 August 2005.